MC Stock Analysis: Moelis | NYSE
Capital Markets | NYSE, USA | Market Cap: 5.099m USD | 12M Return: 10.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 64.4M
Qual. Beats: 0
Rev. Trend: 97.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Moelis & Company is a global investment banking advisory firm founded in 2007 and headquartered in New York. Operating across North and South America, Europe, the Middle East, Asia, and Australia, the firm provides fee-based advisory services spanning mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, including strategic, capital structure, and private capital advisory.
The company serves a diverse client base that includes public multinational corporations, middle market private companies, financial sponsors, entrepreneurs, governments, and sovereign wealth funds. Listed on the NYSE under the ticker MC following its April 2014 IPO, Moelis falls within the Investment Banking & Brokerage sub-industry of the Financials sector, and its partnership-style operating model is a distinguishing feature relative to many larger bulge-bracket peers.
- M&A deal activity rebounds boosting advisory revenue
- Restructuring advisory demand rises amid credit market stress
- Compensation ratio expansion pressures operating margin
| Net Income: 221.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.32 > 0.02 and ΔFCF/TA -2.24 > 1.0 |
| NWC/Revenue: -7.89% < 20% (prev -11.04%; Δ 3.14% < -1%) |
| CFO/TA 0.36 > 3% & CFO 463.0m > Net Income 221.2m |
| Net Debt (114.2m) to EBITDA (300.0m): 0.38 < 3 |
| Current Ratio: 0.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (79.5m) vs 12m ago 1.17% < -2% |
| Gross Margin: 52.86% > 18% (prev 31.66%; Δ 21.19% > 0.5%) |
| Asset Turnover: 122.6% > 50% (prev 106.4%; Δ 16.21% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: -0.09 (Total Current Assets 279.0m - Total Current Liabilities 399.8m) / Total Assets 1.29b |
| B: -0.63 (Retained Earnings -817.3m / Total Assets 1.29b) |
| C: 0.23 (EBIT TTM 287.4m / Avg Total Assets 1.25b) |
| D: 0.73 (Book Value of Equity 487.1m / Total Liabilities 667.0m) |
| Altman-Z'' = -0.37 = B |
| DSRI: 1.13 (Receivables 125.3m/93.3m, Revenue 1.53b/1.28b) |
| GMI: 0.60 (GM 31.66% / 52.86%) |
| AQI: 0.95 (AQ_t 0.54 / AQ_t-1 0.57) |
| SGI: 1.19 (Revenue 1.53b / 1.28b) |
| TATA: -0.19 (NI 221.2m - CFO 463.0m) / TA 1.29b) |
| Beneish M = -3.20 (Cap -4..+1) = AA |
As of July 08, 2026, the stock is trading at USD 69.84 with a total of 547,051 shares traded. Over the past week, the price has changed by +11.02%, over one month by +1.66%, over three months by +22.69% and over the past year by +10.81%.
Current recommended Stop Loss: 63.70 (which is 8.8% or 2.3 ATR below the current price).
Moelis has received a consensus analysts rating of 2.63. Therefore, it is recommended to hold MC.
- StrongBuy: 0
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 2
| Analysts Target Price | 71.7 | 2.7% |
P/E Trailing = 24.6583
P/E Forward = 20.1207
P/S = 3.3324
P/B = 10.1421
P/EG = 1.97
Revenue TTM = 1.53b USD
EBIT TTM = 287.4m USD
EBITDA TTM = 300.0m USD
Long Term Debt = unknown (none)
Short Term Debt = 28.9m USD (from shortTermDebt, last fiscal year)
Debt = 267.2m USD (from shortLongTermDebtTotal, last quarter) (leases 267.2m already included)
Net Debt = 114.2m USD (calculated: Debt 267.2m - CCE 152.9m)
Enterprise Value = 5.21b USD (5.10b + Debt 267.2m - CCE 152.9m)
Interest Coverage Ratio = unknown (Ebit TTM 287.4m / Interest Expense TTM 0.0)
EV/FCF = 12.50x (Enterprise Value 5.21b / FCF TTM 417.0m)
FCF Yield = 8.00% (FCF TTM 417.0m / Enterprise Value 5.21b)
FCF Margin = 27.25% (FCF TTM 417.0m / Revenue TTM 1.53b)
Net Margin = 14.46% (Net Income TTM 221.2m / Revenue TTM 1.53b)
Gross Margin = 52.86% ((Revenue TTM 1.53b - Cost of Revenue TTM 721.3m) / Revenue TTM)
Gross Margin QoQ = 34.20% (prev none%)
Tobins Q-Ratio = 4.04 (Enterprise Value 5.21b / Total Assets 1.29b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 267.2m)
Taxrate = 24.94% (82.4m / 330.6m)
NOPAT = 215.7m (EBIT 287.4m * (1 - 24.94%))
Current Ratio = 0.70 (Total Current Assets 279.0m / Total Current Liabilities 399.8m)
Debt / Equity = 0.55 (Debt 267.2m / totalStockholderEquity, last quarter 487.1m)
Debt / EBITDA = 0.38 (Net Debt 114.2m / EBITDA 300.0m)
Debt / FCF = 0.27 (Net Debt 114.2m / FCF TTM 417.0m)
Total Stockholder Equity = 526.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 17.73% (Net Income 221.2m / Total Assets 1.29b)
RoE = 42.00% (Net Income TTM 221.2m / Total Stockholder Equity 526.6m)
RoCE = 32.31% (EBIT 287.4m / Capital Employed (Total Assets 1.29b - Current Liab 399.8m))
RoIC = 25.63% (NOPAT 215.7m / Invested Capital 841.8m)
WACC = 11.37% (E(5.10b)/V(5.37b) * Re(11.97%) + D(267.2m)/V(5.37b) * Rd(0.0%) * (1-Tc(0.25)))
Discount Rate = 11.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 82.22 | Cagr: 6.20%
[DCF] Terminal Value 65.60% ; FCFF base≈417.0m ; Y1≈418.6m ; Y5≈443.0m
[DCF] Fair Price = 59.67 (EV 4.55b - Net Debt 114.2m = Equity 4.44b / Shares 74.4m; r=11.37% [WACC]; 5y FCF grow -0.05% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.64 | # QB: 0
Revenue Correlation: 97.78 | Revenue CAGR: 31.05% | SUE: -0.09 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.61 | Chg30d=-1.46% | Revisions=+25% | Analysts=11
EPS next Quarter (2026-09-30): EPS=0.78 | Chg30d=+1.20% | Revisions=-62% | Analysts=10
EPS current Year (2026-12-31): EPS=3.09 | Chg30d=-0.15% | Revisions=-25% | GrowthEPS=+3.4% | GrowthRev=+10.2%
EPS next Year (2027-12-31): EPS=3.95 | Chg30d=+0.00% | Revisions=-30% | GrowthEPS=+27.9% | GrowthRev=+19.1%
[Analyst] Revisions Ratio: -29% (up=12, down=23)